Kala Pharmaceuticals logo

Kala Pharmaceuticals

A biopharmaceutical company that develops nanotherapeutic treatments for ocular diseases and other eye related conditions

6

Funding Rounds

$82.8m

Money raised

Overview

A biopharmaceutical company that develops nanotherapeutic treatments for ocular diseases and other eye related conditions

Funding

Funding series

Funding Series Analysis

The company Kala Pharmaceuticals has raised a total of $48.77m in funding over 6 rounds.

Key Insights:

  • Kala Pharmaceuticals Funding Round, November 2021: $36.52m
  • Kala Pharmaceuticals funding round, March 2012: $7.24m
  • Kala Pharmaceuticals Series B round: $3m
  • Kala Pharmaceuticals Series A round: $2m
  • Kala Pharmaceuticals Series A round February 2013: $11.5m
  • Kala Pharmaceuticals Series B round April 2014: $22.5m
Kala Pharmaceuticals logo
Kala Pharmaceuticals Funding Round, November 2021 $36.52m
Kala Pharmaceuticals logo
Kala Pharmaceuticals funding round, March 2012 $7.24m
Kala Pharmaceuticals logo
Kala Pharmaceuticals Series B round $3m
Kala Pharmaceuticals logo
Kala Pharmaceuticals Series A round $2m
Kala Pharmaceuticals logo
Kala Pharmaceuticals Series A round February 2013 $11.5m
Kala Pharmaceuticals logo
Kala Pharmaceuticals Series B round April 2014 $22.5m

Industries

Kala Pharmaceuticals is active in the following industries:
  • Biopharmaceutical
  • Therapeutics
  • Healthcare
  • Therapy
  • Drug delivery
  • Biomedical engineering
  • Technology
  • Biology
  • Biotechnology
  • Engineering